Trial Profile
Effects of miglitol versus nateglinide on postprandial hyperglycaemia and the triglyceride/high density lipoprotein (HDL) cholesterol ratio in diabetic patients with stable coronary artery disease (CAD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2013
Price :
$35
*
At a glance
- Drugs Miglitol (Primary) ; Nateglinide
- Indications Coronary artery disease; Diabetes mellitus
- Focus Therapeutic Use
- 23 Sep 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.